Online Only Articles

CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain
Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain
Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain
Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain
Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain
Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain
Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain
Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain
Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain
Department of Hematology, Gregorio Marañón Institute for Health Research, Madrid, Spain
Department of Hematology, Gregorio Marañón Institute for Health Research, Madrid, Spain
Department of Hematology, Clinical University of Navarra, Pamplona, Spain
Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
Department of Hematology, University Hospital of Salamanca, Salamanca Institute for Biomedical Research (IBSAL), Spain
Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain
Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain
Program of Hematology-Oncology, CIMA, University of Navarra, Pamplona, Spain;Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain
Vol. 100 No. 5 (2015): May, 2015 https://doi.org/10.3324/haematol.2014.118117